MXPA04006120A - Piperidin-2,6-dionas sustitudas heterociclicamente en posicion 3. - Google Patents

Piperidin-2,6-dionas sustitudas heterociclicamente en posicion 3.

Info

Publication number
MXPA04006120A
MXPA04006120A MXPA04006120A MXPA04006120A MXPA04006120A MX PA04006120 A MXPA04006120 A MX PA04006120A MX PA04006120 A MXPA04006120 A MX PA04006120A MX PA04006120 A MXPA04006120 A MX PA04006120A MX PA04006120 A MXPA04006120 A MX PA04006120A
Authority
MX
Mexico
Prior art keywords
diones
piperidine
heterocyclically substituted
heterocyclically
substituted
Prior art date
Application number
MXPA04006120A
Other languages
English (en)
Spanish (es)
Inventor
Theil Fritz
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of MXPA04006120A publication Critical patent/MXPA04006120A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MXPA04006120A 2001-12-21 2002-12-18 Piperidin-2,6-dionas sustitudas heterociclicamente en posicion 3. MXPA04006120A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10163595A DE10163595A1 (de) 2001-12-21 2001-12-21 In 3-Position heterocyclisch substituierte Piperidin-2,6-dione
PCT/EP2002/014447 WO2003053956A1 (de) 2001-12-21 2002-12-18 In 3-position heterocyclisch substituierte piperidin-2,6-dione

Publications (1)

Publication Number Publication Date
MXPA04006120A true MXPA04006120A (es) 2004-11-01

Family

ID=7710600

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04006120A MXPA04006120A (es) 2001-12-21 2002-12-18 Piperidin-2,6-dionas sustitudas heterociclicamente en posicion 3.

Country Status (27)

Country Link
US (1) US7183274B2 (da)
EP (1) EP1456197B1 (da)
JP (1) JP2005516953A (da)
KR (1) KR20040068325A (da)
CN (1) CN1620448A (da)
AR (1) AR037963A1 (da)
AT (1) ATE355285T1 (da)
AU (1) AU2002364286A1 (da)
BR (1) BR0215337A (da)
CA (1) CA2471079A1 (da)
CY (1) CY1106540T1 (da)
DE (2) DE10163595A1 (da)
DK (1) DK1456197T3 (da)
EC (1) ECSP045161A (da)
ES (1) ES2282514T3 (da)
HU (1) HUP0402477A2 (da)
IL (1) IL162619A0 (da)
MX (1) MXPA04006120A (da)
NO (1) NO20042946L (da)
NZ (1) NZ533995A (da)
PE (1) PE20030745A1 (da)
PL (1) PL371028A1 (da)
PT (1) PT1456197E (da)
RU (1) RU2004122633A (da)
SI (1) SI1456197T1 (da)
WO (1) WO2003053956A1 (da)
ZA (1) ZA200405780B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004026703A1 (de) * 2004-05-28 2005-12-29 Grünenthal GmbH Verfahren zur Herstellung von in 3-Position heterocyclisch substituierten Piperidin-2,6-dionen
DE102005057912A1 (de) 2005-12-02 2007-07-19 Grünenthal GmbH In 3-Position heterocyclisch substituierte Pyrrolidin(thi)one
KR200484781Y1 (ko) 2017-07-04 2017-10-25 김정래 지퍼손잡이 보호장치

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0652871B1 (en) * 1992-07-29 2001-10-17 MERCK SHARP & DOHME LTD. Benzodiazepine derivatives
JPH09500134A (ja) * 1993-07-16 1997-01-07 メルク エンド カンパニー インコーポレーテッド ベンゾオキサジノンおよびベンゾピリミジノンピペリジニル早産防止オキシトシン受容体拮抗剤
DE19843793C2 (de) * 1998-09-24 2000-08-03 Gruenenthal Gmbh Substituierte Benzamide
WO2000072836A2 (en) 1999-05-27 2000-12-07 The Rockefeller University Methods of promoting or enhancing interleukin-12 production through administration of thalidomide
US6767926B1 (en) * 1999-10-12 2004-07-27 Temple University - Of The Commonwealth System Of Higher Education Method for protecting normal cells from cytotoxicity of chemotherapeutic agents
DE19957342A1 (de) 1999-11-29 2001-05-31 Gruenenthal Gmbh Verfahren zur Behandlung und/oder Prophylaxe von IL-12-bedingten Erkrankungen
DE10002509A1 (de) * 2000-01-21 2001-07-26 Gruenenthal Gmbh Substituierte Glutarimide
DE10250082A1 (de) * 2002-10-25 2004-05-13 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel

Also Published As

Publication number Publication date
PE20030745A1 (es) 2003-09-05
NZ533995A (en) 2006-11-30
WO2003053956A1 (de) 2003-07-03
CY1106540T1 (el) 2012-01-25
DE50209613D1 (de) 2007-04-12
CA2471079A1 (en) 2003-07-03
PL371028A1 (en) 2005-06-13
EP1456197B1 (de) 2007-02-28
RU2004122633A (ru) 2005-06-10
HUP0402477A2 (hu) 2005-05-30
KR20040068325A (ko) 2004-07-30
BR0215337A (pt) 2004-11-16
ATE355285T1 (de) 2006-03-15
ZA200405780B (en) 2005-07-26
DK1456197T3 (da) 2007-06-11
SI1456197T1 (sl) 2007-08-31
CN1620448A (zh) 2005-05-25
JP2005516953A (ja) 2005-06-09
AR037963A1 (es) 2004-12-22
PT1456197E (pt) 2007-03-30
EP1456197A1 (de) 2004-09-15
ES2282514T3 (es) 2007-10-16
DE10163595A1 (de) 2003-08-07
NO20042946L (no) 2004-09-20
AU2002364286A1 (en) 2003-07-09
US7183274B2 (en) 2007-02-27
IL162619A0 (en) 2005-11-20
ECSP045161A (es) 2004-08-27
US20050020581A1 (en) 2005-01-27

Similar Documents

Publication Publication Date Title
SE0102315D0 (sv) Compounds
HK1096392A1 (en) Substituted heterocycles
AU2002258066A1 (en) Dermatological and cosmetic compositions
BG105783A (en) Triazole compounds with dopamine-d3-receptor affinity
CY1113306T1 (el) Παραγωγα της κινολινης και η χρηση τους ως προσδεματων 5-ht6
IL172773A0 (en) Formulations for the treatment of arhritis conditions
GB0111186D0 (en) Novel compounds
MXPA05009885A (es) Nuevas triazolonas fusionadas y los usos de las mismas.
MXPA03011546A (es) Formulacion farmaceutica.
MXPA03008423A (es) Agonistas del receptor nicotinico para el tratamiento de enfermedades inflamatorias.
YU87202A (sh) Derivati arilmetilamina koji se koriste kao inhibitori triptaze
WO2003106450A8 (de) Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren
SE0203825D0 (sv) Novel fused heterocycles and uses thereof
BR0209541A (pt) Uso das imidazotriazinonas 2-fenil-substituìdas
IL163951A (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
HK1112228A1 (en) Substituted azachinzolines having an antiviral action
GB0320320D0 (en) Novel compounds
NO20010940D0 (no) TAN-1057 derivater
MY140081A (en) Pharmaceutical formulations of modafinil
MXPA04006120A (es) Piperidin-2,6-dionas sustitudas heterociclicamente en posicion 3.
UY27312A1 (es) Nuevos heterociclos 3
WO2003024996A3 (de) Antibakterielle makrozyklen
DE50203154D1 (de) Benzimidazolderivate zur behandlung von mit mikroglia-aktivierung assoziierten erkrankungen wie inflammatorische, allergische, infektiöse oder autoimmune erkrankungen
DE60003074D1 (de) Fusidinsäure-derivate
WO2004100973A3 (en) Pharmaceutical compositions of antithrombin iii for the treatment of retroviral diseases.

Legal Events

Date Code Title Description
FG Grant or registration